JPY 555.0
(-0.54%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 4.5 Billion JPY | 7.94% |
2022 | 4.16 Billion JPY | 8.78% |
2021 | 3.83 Billion JPY | -1.38% |
2020 | 3.88 Billion JPY | -14.68% |
2019 | 4.55 Billion JPY | -6.36% |
2018 | 4.86 Billion JPY | 71.49% |
2017 | 2.83 Billion JPY | -0.87% |
2016 | 2.86 Billion JPY | 3.72% |
2015 | 2.75 Billion JPY | 1.17% |
2014 | 2.72 Billion JPY | 16.92% |
2013 | 2.33 Billion JPY | -34.8% |
2012 | 3.57 Billion JPY | 16.52% |
2011 | 3.06 Billion JPY | 4.76% |
2010 | 2.93 Billion JPY | 7.66% |
2009 | 2.72 Billion JPY | 6.64% |
2008 | 2.55 Billion JPY | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.04 Billion JPY | -4.21% |
2024 Q1 | 1.09 Billion JPY | -16.42% |
2024 Q3 | 1.1 Billion JPY | 5.87% |
2023 Q4 | 1.3 Billion JPY | 20.43% |
2023 FY | 4.5 Billion JPY | 7.94% |
2023 Q1 | 1.08 Billion JPY | -9.79% |
2023 Q2 | 1.02 Billion JPY | -5.28% |
2023 Q3 | 1.08 Billion JPY | 6.02% |
2022 Q1 | 973.02 Million JPY | -6.23% |
2022 Q2 | 939.99 Million JPY | -3.39% |
2022 FY | 4.16 Billion JPY | 8.78% |
2022 Q3 | 1.05 Billion JPY | 12.47% |
2022 Q4 | 1.19 Billion JPY | 13.41% |
2021 Q3 | 940.18 Million JPY | 6.64% |
2021 FY | 3.83 Billion JPY | -1.38% |
2021 Q1 | 972.99 Million JPY | 7.43% |
2021 Q2 | 881.65 Million JPY | -9.39% |
2021 Q4 | 1.03 Billion JPY | 10.37% |
2020 Q1 | 1.08 Billion JPY | -0.68% |
2020 FY | 3.88 Billion JPY | -14.68% |
2020 Q4 | 905.69 Million JPY | -3.83% |
2020 Q3 | 941.75 Million JPY | -1.43% |
2020 Q2 | 955.37 Million JPY | -11.8% |
2019 FY | 4.55 Billion JPY | -6.36% |
2019 Q1 | 1.27 Billion JPY | 7.53% |
2019 Q4 | 1.09 Billion JPY | -1.82% |
2019 Q3 | 1.11 Billion JPY | 2.67% |
2019 Q2 | 1.08 Billion JPY | -14.9% |
2018 Q4 | 1.18 Billion JPY | -6.22% |
2018 Q3 | 1.26 Billion JPY | 7.02% |
2018 Q2 | 1.17 Billion JPY | -5.22% |
2018 Q1 | 1.24 Billion JPY | 284.95% |
2018 FY | 4.86 Billion JPY | 71.49% |
2017 Q4 | -672.01 Million JPY | -155.19% |
2017 Q2 | 1.15 Billion JPY | 1.18% |
2017 FY | 2.83 Billion JPY | -0.87% |
2017 Q1 | 1.13 Billion JPY | 279.63% |
2017 Q3 | 1.21 Billion JPY | 5.71% |
2016 Q1 | 1.18 Billion JPY | 280.68% |
2016 Q4 | -633.82 Million JPY | -153.48% |
2016 FY | 2.86 Billion JPY | 3.72% |
2016 Q3 | 1.18 Billion JPY | 5.23% |
2016 Q2 | 1.12 Billion JPY | -4.86% |
2015 Q1 | 1.2 Billion JPY | 342.33% |
2015 FY | 2.75 Billion JPY | 1.17% |
2015 Q4 | -655.11 Million JPY | -157.55% |
2015 Q3 | 1.13 Billion JPY | 6.1% |
2015 Q2 | 1.07 Billion JPY | -10.75% |
2014 Q2 | 1 Billion JPY | -6.68% |
2014 Q1 | 1.07 Billion JPY | 336.1% |
2014 Q3 | 1.14 Billion JPY | 13.51% |
2014 FY | 2.72 Billion JPY | 16.92% |
2014 Q4 | -496.11 Million JPY | -143.49% |
2013 Q3 | 977.59 Million JPY | 14.32% |
2013 Q4 | -456.15 Million JPY | -146.66% |
2013 Q2 | 855.14 Million JPY | -10.51% |
2013 Q1 | 955.53 Million JPY | 51.39% |
2013 FY | 2.33 Billion JPY | -34.8% |
2012 Q2 | 1.01 Billion JPY | 1.54% |
2012 Q1 | 1 Billion JPY | 58.3% |
2012 Q4 | 631.15 Million JPY | -31.75% |
2012 Q3 | 924.77 Million JPY | -9.17% |
2012 FY | 3.57 Billion JPY | 16.52% |
2011 Q4 | 633.38 Million JPY | -26.65% |
2011 Q1 | 803.63 Million JPY | 33.7% |
2011 FY | 3.06 Billion JPY | 4.76% |
2011 Q3 | 863.47 Million JPY | 12.19% |
2011 Q2 | 769.62 Million JPY | -4.23% |
2010 FY | 2.93 Billion JPY | 7.66% |
2010 Q1 | 761.64 Million JPY | 37.92% |
2010 Q3 | 836.45 Million JPY | 14.38% |
2010 Q2 | 731.26 Million JPY | -3.99% |
2010 Q4 | 601.09 Million JPY | -28.14% |
2009 Q2 | 683.41 Million JPY | 0.0% |
2009 Q4 | 552.24 Million JPY | -30.13% |
2009 Q3 | 790.39 Million JPY | 15.65% |
2009 FY | 2.72 Billion JPY | 6.64% |
2008 FY | 2.55 Billion JPY | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Kitanotatsujin Corporation | 9.38 Billion JPY | 52.037% |
Euglena Co., Ltd. | 34.45 Billion JPY | 86.937% |
BEAUTY GARAGE Inc. | 5.8 Billion JPY | 22.411% |
Axas Holdings Co.,Ltd. | 3 Billion JPY | -49.991% |
C.I. Medical Co.,Ltd. | 9 Billion JPY | 50.029% |
Kao Corporation | 438.95 Billion JPY | 98.975% |
Niitaka Co., Ltd. | 6.65 Billion JPY | 32.424% |
Rohto Pharmaceutical Co.,Ltd. | 117.23 Billion JPY | 96.161% |
Shiseido Company, Limited | 696.62 Billion JPY | 99.354% |
Lion Corporation | 160.09 Billion JPY | 97.189% |
Mandom Corporation | 29.51 Billion JPY | 84.75% |
Ivy Cosmetics Corporation | 1.72 Billion JPY | -160.835% |
Milbon Co., Ltd. | 24 Billion JPY | 81.248% |
Nippon Shikizai, Inc. | 2.31 Billion JPY | -94.674% |
Fancl Corporation | 61.61 Billion JPY | 92.696% |
KOSÉ Corporation | 189.85 Billion JPY | 97.63% |
Cota Co., Ltd. | 4.25 Billion JPY | -5.813% |
HABA Laboratories,Inc. | 8.21 Billion JPY | 45.21% |
C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | 29.357% |
Pola Orbis Holdings Inc. | 119.68 Billion JPY | 96.24% |
Noevir Holdings Co., Ltd. | 31.54 Billion JPY | 85.731% |
Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -57.266% |
Almado, Inc. | 4.11 Billion JPY | -9.485% |
I-ne CO., LTD. | 17.86 Billion JPY | 74.809% |
Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | 71.804% |
Liberta Co.,Ltd. | 2.68 Billion JPY | -67.854% |
AXXZIA Inc. | 8.57 Billion JPY | 47.502% |
S.T. Corporation | 15.07 Billion JPY | 70.143% |
Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | 93.625% |
Earth Corporation | 57.25 Billion JPY | 92.14% |
Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -186.512% |
Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -246.594% |
Ya-Man Ltd. | 18.49 Billion JPY | 75.671% |
MTG Co., Ltd. | 33.26 Billion JPY | 86.47% |
TRANSACTION CO.,Ltd. | 4.57 Billion JPY | 1.662% |
Artnature Inc. | 25.01 Billion JPY | 82.009% |
Pigeon Corporation | 34.72 Billion JPY | 87.041% |
Unicharm Corporation | 351.52 Billion JPY | 98.72% |
Paltac Corporation | 53.06 Billion JPY | 91.519% |
CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | 67.353% |